AIP
SAGE

Ameritas Investment Partners’s Sage Therapeutics SAGE Stock Holding History

Ameritas Investment Partners’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,253
Closed -$47.9K – 3202
2025
Q2 		$47.9K Hold
5,253
– – ﹤0.01% 2207
2025
Q1 		$41.8K Hold
5,253
– – ﹤0.01% 2212
2024
Q4 		$28.5K Hold
5,253
– – ﹤0.01% 2482
2024
Q3 		$37.9K Hold
5,253
– – ﹤0.01% 2348
2024
Q2 		$57K Hold
5,253
– – ﹤0.01% 2073
2024
Q1 		$98.4K Hold
5,253
– – ﹤0.01% 1753
2023
Q4 		$114K Hold
5,253
– – ﹤0.01% 1646
2023
Q3 		$108K Buy
5,253
+887
+20% +$25.6K ﹤0.01% 1600
2023
Q2 		$205K Buy
4,366
+198
+5% +$9.85K 0.01% 1118
2023
Q1 		$175K Hold
4,168
– – 0.01% 1181
2022
Q4 		$178K Buy
4,168
+261
+7% +$9.97K 0.01% 1218
2022
Q3 		$152K Hold
3,907
– – 0.01% 1215
2022
Q2 		$126K Buy
+3,907
New +$131K 0.01% 1354
2018
Q2 		– Sell
-3,534
Closed -$569K – 3056
2018
Q1 		$569K Buy
3,534
+280
+9% +$47.5K 0.03% 710
2017
Q4 		$536K Buy
3,254
+220
+7% +$21.3K 0.02% 729
2017
Q3 		$249K Hold
3,034
– – 0.01% 946
2017
Q2 		$242K Buy
3,034
+497
+20% +$35.9K 0.01% 960
2017
Q1 		$180K Buy
+2,537
New +$149K 0.01% 1115

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ameritas Investment Partners's SAGE Position: Q3 2025 in Review

Ameritas Investment Partners sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 5,253 shares — an estimated $47.9K sold.

Ameritas Investment Partners first reported a position in SAGE in Q1 2017 and held it in 18 quarters. The position peaked at $569K in Q1 2018. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Ameritas Investment Partners reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 5,253 Sage Therapeutics shares in Q3 2025, an estimated $47.9K.
  • Ameritas Investment Partners first reported a position in Sage Therapeutics in Q1 2017 and held it in 18 quarters.
  • Ameritas Investment Partners's Sage Therapeutics position peaked at $569K in Q1 2018.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Ameritas Investment Partners's 13F filing for Q3 2025, filed 10 Nov 2025.